Novartis’s Beovu Launch Clouded By Safety Worries

Beovu Uncertainty Should Benefit Regeneron’s Eylea

 
• By Sten Stovall
Macular degeneration
Beovu safety worries raised by American Society of Retinal Specialists

More from Sensory

More from Therapeutic Category